Jiangsu Jibeier Pharmaceutical Co. Ltd. Class ASSE: 688566

Announcement on Voluntary Disclosure Regarding the Approval Notice for Drug Clinical Trials of the Investigational Anti-Tumor Drug JJH201601 Liposome for Injection

· Issued by Jiangsu Jibeier Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure Regarding the Approval Notice for Drug Clinical Trials of the Investigational Anti-Tumor Drug JJH201601 Liposome for Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis